Thank god you are right. It has turned into the best possible scenrio. If Roche had bought AGPH, the stock would have turned into a dog. If Syntex had continued, AGPH would have turned into the definition of mismanagement. The way it stands now is : Two Sugar Daddies, No viable 'non-insider' insiders holding stock, top of the line managers controlling, individual investor controlled, company focused on shareholder interest, company focused on expansion, main-line science, etc.
If I insulted your stock picks, I apologize. I focus on growth with the potention of becoming large cap. Frankly, I do follow CHIR. I just think it is still a little early.
As far as cancer and rhinovirus, combined they may add $200 million. On the other hand, they bought Alanex for a song. One winner out of the 6,000 possible, would be good, Two would be exceptional. |
